assessment of
upper extremity function via the use of the Disabilities of the
Arm, Shoulder and Hand (DASH) Questionnaire [16]. Both
secondary endpoints were evaluated on the 10th treatment
day as well as 3 months following completion of therapy and
compared to baseline.